Evofem Biosciences Announces Issuance Of US Patent No. 11,992,472 Covering Composition And Methods For Contraception With Phexxi Vaginal Gel
Evofem Biosciences Announces Issuance Of US Patent No. 11,992,472 Covering Composition And Methods For Contraception With Phexxi Vaginal Gel
evofem biosciences宣佈發行了美國專利號11,992,472，覆蓋了使用phexxi****凝膠進行避孕的組合物和方法。
- Issuance of U.S. Patent No. 11,992,472 Further Strengthens Evofem's Intellectual Patent Portfolio --
- 發放了美國專利第11,992,472號，進一步加強Evofem的知識產權組合--
- Newly issued patent is Evofem's fifth covering Hormone-Free "In the Moment" Contraceptive Phexxi in the United States
- 新發放的專利是Evofem在美國涵蓋無激素“即時”避孕藥Phexxi方面的第五項專利
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。